Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
FrontWave Imaging is a developer of supercomputing software that helps with the diagnosis of breast cancer.
Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase
OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.
Inrobics proposes a rehabilitation model using artificial intelligence and social robots.
Biohope is dedicated to the development of diagnostic and therapeutic solutions for organ transplantation.
MgShell manufactures intraocular devices for treating exudative form of age-related macular degeneration.
Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
MOWOOT is a Non-pharmacological & Non-invasive solution for people suffering from chronic constipation.
MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for MSI cancers.
EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.
MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction.
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.
The ultimate solution for aortic diseases
Corify Care is the developer of an innovative and completely non-invasive cardiac mapping system.
Vytrus Biotech was born as a spin-off company of the Faculty of Pharmacy at the University of Barcelona
Ability Pharmaceuticals is a drug discovery and development company.
Braingaze develops mind tracking solutions that solve major challenges around cognitive disorders like ADHD and Mild Cognitive Impairment
Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
In vitro diagnostic company that develops a rapid test for a faster sepsis diagnose through host immune system status.
Exheus is provider of direct-to-consumer gene expression report that helps to optimise people’s health in a highly personalised way.
Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.
Capital Cell has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Capital Cell's top investment sectors include Health Care, Biotechnology, Medical, Health Diagnostics, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Aortyx received $16.0M in a Series A round. Capital Cell's total known invested capital is $93.3M.
Capital Cell's average investment size is $2.4M across its portfolio of 46 companies.
Recent Capital Cell portfolio additions include FrontWave Imaging, Oncostellae, OxyPrem, Inrobics, Biohope. These companies were founded in 2020 or later.